Abstract
Photodynamic therapy (PDT), which utilizes a photoactivated drug (photosensitizer) to destroy malignant or certain other undesirable tissue, is approved by health agencies worldwide, mainly for the treatment of early- and late-stage lung cancer and premalignant and obstructive esophageal cancer. The clinical and scientific development of PDT began in the early 1970s at Roswell Park Cancer Institute in Buffalo, NY. This paper presents the history of this process at Roswell Park.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Henderson BW, Gollnick SO. Mechanistic principles of photodynamic therapy, in CRC Handbook of Organic Photochemistry and Photobiology (Horspool W, Lenci F, eds.), Boca Raton, FL: CRC Press, 2003:145–1–145–25.
Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889–905.
Raab O. Ueber die Wirkung fluoreszierender Stoffe auf Infusorien. Z Biol (Munich) 1900;39: 524–546.
Dougherty TJ. Activated dyes as anti-tumor agents. J Natl Cancer Inst 1974;51:1333–1336.
Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975;55:115–121.
Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittelman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978;38:2628–2635.
Kelly JF, Snell ME. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 1976;115:150–151.
Lipson RL, Baldes EJ, Olsen AM. Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg 1962:623–629.
Lipson RL, Gray MJ, Baldes EJ. Hematoporphyrin derivative for detection and management of cancer, in Proceedings of the 9th International Cancer Congress, 1966.
Dougherty TJ, Lawrence G, Kaufman JH, Boyle D, Weishaupt KR, Goldfarb A. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979;62:231–237.
Hayata Y, Kato H, Konaka C, Ono J, Takizawa N. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982;81:269–277.
McCaughan JS. Overview of experiences with photodynamic therapy for malignancy in 192 patients. Photochem Photobiol 1987;46:903–909.
Thoma RE, Stein RM, Weishaupt KR, Dougherty TJ. Phototherapy: a promising cancer therapy. Vet Med/Small Anim Clinician 1989;33;1693–1699.
Christensen T, Moan J, Wibe E, Oftebro R. Photodynamic effect of haematoporphyrin throughout the cell cycle of the human cell line NHIK 3025 cultivated in vitro. Br J Cancer 1979;39:64–68.
Moan J, Pettersen EO, Christensen T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br J Cancer 1979:398–407.
Kessel D. Components of hematoporphyrin derivatives and their tumor-localizing capacity. Cancer Res 1982;42:1703–1706.
Henderson BW. The significance of vascular photosensitization in photodynamic therapy. Future Dir Applic Photodyn Ther 1990;156:153–166.
Henderson BW, Farrell G. Possible implications of vascular damage for tumor cell inactivation in vivo: comparison of different photosensitizers, in Photodynamic Therapy: Mechanisms (Dougherty TJ, ed.), Bellingham, WA: SPIE—The International Society for Optical Engineering, 1989:2–10.
Siegel MM, Tabei K, Tsao R, et al. Comparative mass spectrometric analyses of Photofrin oligomers by fast atom bombardment mass spectrometry, UV and IR matrix-assisted laser desorption/ionization mass spectrometry, electrospray ionization mass spectrometry and laser desorption/jet-cooling photoionization mass spectrometry. J Mass Spectrom 1999;34:661–669.
Lam S, Haussinger K, Leroy M, Sutedja T, Huber R. Photodynamic therapy (PDT) with Photofrin®, a treatment with curative potential for early stage superficial lung cancer. Proceedings of the 34th Annual Meeting of the American Society of Clinical Oncology, 1998.
Balchum OJ, Doiron DR. Photoradiation therapy of endobronchial lung cancer. Large obstructing tumors, nonobstructing tumors, and early-stage bronchial cancer lesions. Clin Chest Med 1985;6: 255–275.
Balchum OJ, Doiron DR, Huth GC. HpD photodynamic therapy for obstructing lung cancer. Prog Clin Biol Res 1984;170:727–745.
Bellnier DA, Greco WR, Loewen GM, et al. Population pharmacokinetics of the photodynamic therapy agent 2-[-1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Res 2003;63:1806–1813.
Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-1-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a) for photodynamic therapy. Cancer Chemother Pharmacol 2006;57:40–45.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Dougherty, T.J. (2007). A Personal History of Photodynamic Therapy. In: Schlag, P.M., Stein, U., Eggermont, A.M.M. (eds) Regional Cancer Therapy. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-59745-225-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-59745-225-0_9
Publisher Name: Humana Press
Print ISBN: 978-1-58829-672-6
Online ISBN: 978-1-59745-225-0
eBook Packages: MedicineMedicine (R0)